Nosocomial pneumonia is a leading cause of death from hospital-acquired infections, with
an associated crude mortality rate of approximately 30 percent. 1 Ventilator-associated …

Purpose Current treatment for febrile neutropenia (FN) includes hospitalization for
evaluation, empiric broad-spectrum antibiotics, and other supportive care. Clinical trials …

This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

BACKGROUND Hospitalization for febrile neutropenia (FN) in cancer patients is associated
with considerable morbidity, mortality, and cost. The study was undertaken to better define …

This report updates, expands, and replaces the previously published CDC" Guideline for
Prevention of Nosocomial Pneumonia". The new guidelines are designed to reduce the …

This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and
Neutropenia Guidelines Panel, updates guidelines established a decade ago by the …

2000 update of recommendations for the use of hematopoietic colony-stimulating factors:
evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth …

Guidelines for Preventing Health-Care-Associated Pneumonia, 2003 Recommendations of the
CDC and the Healthcare Infection Control Page 1 Special Articles Guidelines for Preventing …

Objective: To evaluate the trend in incidence ofPseudomonas aeruginosabacteremia,
underlying conditions of patients, mortality rate, and factors associated with poor outcome …

Neutropenia and its subsequent infectious complications represent the most common dose-
limiting toxicity of cancer chemotherapy. Febrile neutropenia (FN) occurs with common …